Results 221 to 230 of about 115,341 (318)

Is Single‐Session Peroral Endoscopic Myotomy With Fundoplication Safe and Effective in Achalasia? A Systematic Review and Meta‐Analysis

DEN Open, Volume 6, Issue 1, April 2026.
This meta‐analysis of nine studies (202 patients) demonstrates that peroral endoscopic myotomy with fundoplication (POEM‐F) achieves a technical success of 94.8% and significant symptom improvement (Eckardt score reduction from 8.3 to 1.1). Post‐procedural esophagitis occurred in 20.7% and wrap integrity was preserved in 75.7% on follow‐up, supporting ...
Yusuf Kagzi, Abuzar Asif, Srinivas Reddy Puli   +2 more
wiley   +1 more source

The Interplay Between Esophageal Adenocarcinoma and Its Tumor Microenvironment: Toward Innovative Therapies. [PDF]

Cells
Fioretzaki R, Trifylli EM, Sarantis P, Charalampakis N, Christofidis K, Despotidis M, Karamouzis MV, Sakellariou S, Schizas D.   +8 more
europepmc   +1 more source

Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma [PDF]

, 2019
Lars M. Schiffmann, Heike Göbel, Heike Löser, Fabian Schorn, J Paul Werthenbach, Hans F. Fuchs, Patrick Sven Plum, Marc Bludau, Thomas Zander, Wolfgang Schröder, Christiane J. Bruns, Hamid Kashkar, Alexander Quaas, Florian Gebauer   +13 more
openalex   +1 more source

Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real‐world matched comparison of overall survival

International Journal of Cancer, Volume 158, Issue 5, Page 1292-1301, 1 March 2026.
What's New? Patients with esophageal or gastroesophageal junction (GEJ) cancer with residual disease after treatment with neoadjuvant chemoradiotherapy (nCRT) and resection frequently experience poor survival. Improvements in outcome, however, may be possible using adjuvant treatment with nivolumab.
Rob H. A. Verhoeven, Steven C. Kuijper, Marije Slingerland, Bas Wijnhoven, Mark I. van Berge Henegouwen, Peter S. N. van Rossum, Sarah Derks, Bianca Mostert, Nadia Haj Mohammad, Hanneke W. M. van Laarhoven   +9 more
wiley   +1 more source

Synergistic Disruption of Survival and Metastatic Potential in Esophageal Adenocarcinoma Cells Through Combined Inhibition of HIF1α and CD73. [PDF]

Cancers (Basel)
Mersich I, Malmberg A, Anik E, Hassan MS, von Holzen U, Blagg BSJ, Ali A.   +6 more
europepmc   +1 more source

Genomic regions associated with susceptibility to Barrett\u27s esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study [PDF]

, 2017
et al.,, Nalbantoglu, Ilke, Wang, Jean S
core   +1 more source

Diabetes in relation to Barrett’s esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett’s and Esophageal Adenocarcinoma Consortium [PDF]

, 2019
Jessica L. Petrick, Nan Li, Lesley Anderson, Leslie Bernstein, Douglas A. Corley, Hashem B. El‐Serag, Sheetal Hardikar, Linda M. Liao, Geoffrey Liu, Liam Murray, Joel H. Rubenstein, Jennifer L. Schneider, Nicholas J. Shaheen, Aaron P. Thrift, Piet A. van den Brandt, Thomas L. Vaughan, David C. Whiteman, Anna H. Wu, Wei Zhao, Marilie D. Gammon, Michael B. Cook   +20 more
openalex   +1 more source

Local Anesthetics in Cancer: Mechanisms and Translational Perspectives

MedComm – Oncology, Volume 5, Issue 1, March 2026.
Local anesthetics demonstrate multifaceted antitumor effects that collectively contribute to cancer suppression. Beyond canonical sodium channel blockade, these agents exert the following pharmacological actions: inhibition of tumor cell proliferation, suppression of migration and invasion, induction of proapoptotic pathways, attenuation of ...
Wan‐li Wang, Tu Huang, Yi‐hang Hao, Min Zheng, Xin‐hua Liang   +4 more
wiley   +1 more source

Impact of Alpha-mangostin on human esophageal adenocarcinoma cells reveals activation of key apoptotic signaling pathways. [PDF]

Discov Oncol
Canary C, Patil K, Dominick VM, Quintero C, Rojas M, Barnes M, Pai SB.   +6 more
europepmc   +1 more source

Targeting Tumor Dormancy and Recurrence: Molecular Mechanisms and Peptide Therapeutic Delivery

MedComm – Oncology, Volume 5, Issue 1, March 2026.
This review summarizes the molecular mechanisms that regulate tumor dormancy and its role in cancer recurrence, with emphasis on immune evasion, extracellular matrix remodeling, metabolic regulation and angiogenic switching. It further discusses emerging peptide–based therapeutic strategies aimed at detecting, modulating, and eliminating dormant tumor ...
Abdur Raheem Aleem, Atif Ali, Wajid Ali, Yuying Cheng, Zhibin Yan, Chaoyi Xia, Chenguang Liu, Caiyun Fu, Yiren Hu, Xi Wang   +9 more
wiley   +1 more source